Susquehanna International Group, LLP Cti Biopharma Corp Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 16, 2023	BUY	$4.2 - $6.01 $364,980 - $522,269	86,900 Added 73.27%	205,500 $863,000
Q4 2022 Feb 14, 2023	SELL	$4.45 - $6.17 $1.46 Million - $2.02 Million	-327,200 Reduced 73.4%	118,600 $712,000
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $746,112 - $1.03 Million	139,200 Added 45.4%	445,800 $2.6 Million
Q2 2022 Aug 15, 2022	BUY	$3.55 - $6.27 $166,495 - $294,063	46,900 Added 18.06%	306,600 $1.83 Million
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $225,720 - $621,324	118,800 Added 84.32%	259,700 $1.21 Million
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.86 $184,464 - $366,366	128,100 Added 1000.78%	140,900 $349,000
Q3 2021 Nov 15, 2021	SELL	$2.25 - $3.18 $485,100 - $685,608	-215,600 Reduced 94.4%	12,800 $38,000
Q2 2021 Aug 11, 2021	BUY	$2.16 - $2.62 $265,032 - $321,474	122,700 Added 116.08%	228,400 $571,000
Q1 2021 May 17, 2021	SELL	$2.68 - $3.8 $117,920 - $167,200	-44,000 Reduced 29.39%	105,700 $308,000
Q4 2020 Feb 16, 2021	SELL	$2.48 - $3.8 $128,216 - $196,460	-51,700 Reduced 25.67%	149,700 $482,000
Q3 2020 Nov 16, 2020	BUY	$1.02 - $2.15 $187,986 - $396,245	184,300 Added 1077.78%	201,400 $433,000
Q2 2020 Aug 14, 2020	BUY	$0.88 - $1.32 $2,640 - $3,960	3,000 Added 21.28%	17,100 $20,000
Q1 2020 May 15, 2020	SELL	$0.69 - $1.54 $42,021 - $93,786	-60,900 Reduced 81.2%	14,100 $13,000
Q4 2019 Feb 14, 2020	BUY	$0.72 - $1.64 $26,856 - $61,171	37,300 Added 98.94%	75,000 $119,000
Q3 2019 Nov 14, 2019	SELL	$0.64 - $0.92 $70,528 - $101,384	-110,200 Reduced 74.51%	37,700 $31,000
Q2 2019 Aug 14, 2019	BUY	$0.8 - $1.03 $88,960 - $114,536	111,200 Added 303.0%	147,900 $127,000
Q1 2019 May 15, 2019	BUY	$0.9 - $1.37 $21,510 - $32,743	23,900 Added 186.72%	36,700 $36,000
Q4 2018 Feb 14, 2019	SELL	$0.73 - $2.19 $2,409 - $7,227	-3,300 Reduced 20.5%	12,800 $9,000
Q3 2018 Nov 14, 2018	SELL	$1.72 - $5.24 $88,064 - $268,288	-51,200 Reduced 76.08%	16,100 $35,000
Q2 2018 Aug 14, 2018	SELL	$3.81 - $5.26 $51,435 - $71,010	-13,500 Reduced 16.71%	67,300 $335,000
Q1 2018 May 15, 2018	BUY	$2.7 - $4.06 $143,370 - $215,585	53,100 Added 191.7%	80,800 $315,000
Q4 2017 Feb 14, 2018	SELL	$2.47 - $3.34 $62,738 - $84,836	-25,400 Reduced 47.83%	27,700 $74,000
Q3 2017 Nov 14, 2017	BUY	$3.12 - $3.65 $165,672 - $193,815	53,100	53,100 $169,000

About CTI BIOPHARMA CORP

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

More about CTIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account